"An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination vaccines."
Court’s inaction creates confusion in the states.
PCMA voiced support for a series of legislative and regulatory reforms.
The new investment phase builds on over 34 years years of serving the needs of U.S. patients and healthcare providers.
Key-Pak with Med-Con integration delivers cost-effective digital monitoring—boosting compliance, improving data quality, and empowering study teams.
This legislation mandates that beginning July 1, 2026, private and public health plans in Hawai'i must reimburse licensed pharmacists for covered health services of contracted pharmacists when those services are delivered within pharmacists' scope of practice.
“Each brings a wealth of leadership experience, strategic insight, and a deep commitment to consumer health and wellness.”
The removed provisions—a ban on PBM spread pricing in Medicaid managed care and a reimbursement rate floor—were included in both the House bill and the Senate Finance Committee's version.
Changes to the schedule could limit access to certain immunizations
"This committee is not in competition with other committees, organizations, or each other – we are all in competition with the infectious diseases and we will work together to ensure the best outcomes for public health."
Eastern District of Pennsylvania Judge Mitchell Goldberg ruled that Caremark inflated Medicare Part D prices to offset other costs.
The appointment comes as PillSafe readies its product for commercial launch in early 2026.
Members of its leadership team shared their strategies to continue to maximize the company’s potential, including making multiple investments in new facilities featuring the latest automation, technology-enabled customer solutions, and strategic acquisitions.
In a roundtable discussion hosted by HHS, health insurers pledged six key reforms aimed at cutting red tape, accelerating care decisions, and enhancing transparency for patients and providers.
92% of prescriptions could have been filled at a lower price, with better information on pricing, dispensing options and manufacturer cost-savings programs.
Company is committed to distinctive actions that will make it easier to navigate the health care system, access care, and achieve better health.
